BioCentury
ARTICLE | Politics, Policy & Law

Leadership and responsibility

Decibel’s Holtzman on core biotech values in the Trump era

December 29, 2016 12:55 AM UTC

In the presidential election, a significant proportion of American voters, feeling unspoken for and left behind by establishment politicians and policies, expressed their displeasure and desire for change. The campaign also gave voice to disturbing currents of thought - a disregard for science, a lack of respect for defined social groups and a view that the modern corporation’s sole responsibility is maximizing the profit of its owners.

The leadership of the biotechnology industry has deep reasons, based in the founding tenets of our industry, to raise our voices in opposition to these troubling ways of thinking. As the Trump administration takes over this month, I want to suggest the biotech industry’s leadership has not yet risen to the occasion...

BCIQ Company Profiles

Decibel Therapeutics Inc.